Laboratory markers of disease activity

Area of Science:

• Clinical immunology
• Laboratory medicine
• Rheumatology

Background:

• Rheumatoid arthritis (RA) presents with various laboratory abnormalities.
• These markers are primarily used for disease monitoring.
• They can also offer prognostic insights and aid in clinical diagnosis.

Purpose of the Study:

• To evaluate the utility of laboratory markers in rheumatoid arthritis.
• To differentiate the roles of quantitative and qualitative markers.
• To identify markers for predicting disease progression and guiding therapy.

Main Methods:

• Review of laboratory markers associated with rheumatoid arthritis.
• Analysis of marker application in early versus established disease stages.
• Assessment of predictive value for radiological erosions.

Main Results:

• Quantitative markers are generally used for monitoring early rheumatoid arthritis.
• Qualitative markers, including MHC conserved epitope and rheumatoid factor, show strong potential for predicting radiological erosions.
• In established RA, most quantitative measures indicate a poor prognosis.

Conclusions:

• The selection of an appropriate laboratory marker is contingent upon the specific clinical question and the stage of rheumatoid arthritis.
• Qualitative markers offer valuable prognostic information, particularly for guiding early therapeutic interventions.
• Laboratory markers play a crucial role in both monitoring rheumatoid arthritis and predicting its long-term outcomes.